Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.55 |
| ▸ | MAPT | P10636 | 2/20 | 0.55 |
| ▸ | HPGD | P15428 | 1/20 | 0.55 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.55 |
| ▸ | MEN1 | O00255 | 4/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | FAAH | O00519 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12404098 | 1.00 | ALDH1A1 (0.55) | ALDH1A1MAPTHPGDNPSR1HSD17B10 | |
| SCHEMBL11051182 | 0.92 | ALDH1A1 (0.48) | ALDH1A1MAPTHPGDNPSR1HSD17B10 | |
| SCHEMBL11051190 | 0.92 | ALDH1A1 (0.48) | ALDH1A1MAPTHPGDNPSR1HSD17B10 | |
| SCHEMBL21494357 | 0.85 | ALDH1A1 (0.49) | ALDH1A1MAPTHPGDNPSR1HSD17B10 | |
| SCHEMBL5523736 | 0.84 | L3MBTL1 (0.59) | ALDH1A1NPSR1MEN1KMT2AL3MBTL1 | |
| SCHEMBL5523733 | 0.84 | L3MBTL1 (0.59) | ALDH1A1NPSR1MEN1KMT2AL3MBTL1 | |
| SCHEMBL16499644 | 0.84 | ALDH1A1 (0.52) | ALDH1A1MAPTHPGDNPSR1HSD17B10 | |
| SCHEMBL16499815 | 0.84 | ALDH1A1 (0.52) | ALDH1A1MAPTHPGDNPSR1HSD17B10 | |
| SCHEMBL16499642 | 0.84 | ALDH1A1 (0.52) | ALDH1A1MAPTHPGDNPSR1HSD17B10 | |
| Benzyl Alcohol SCHEMBL27670531 | 0.83 | ALDH1A1 (0.57) | ALDH1A1MAPTHPGDNPSR1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250091983-A1 | CYCLOPENTANE AND CYCLOHEXANE VARIANTS OF 6-PHENYLHEXANAMIDE MITOFUSIN ACTIVATORS AND METHODS FOR USE THEREOF | MITOCHONDRIA EMOTION, INC. (US) | 2025-03-20 | — | — | US | disclosed |
| WO-2023067515-A1 | THIADIAZOLYL COMPOUNDS AS DNA POLYMERASE THETA INHIBITORS | IDEAYA BIOSCIENCES, INC. (US) | 2023-04-27 | — | — | WO | disclosed |
| WO-2023014828-A2 | CYCLOPENTANE AND CYCLOHEXANE VARIANTS OF 6-PHENYLHEXANAMIDE MITOFUSIN ACTIVATORS AND METHODS FOR USE THEREOF | MITOCHONDRIA EMOTION, INC. (US) | 2023-02-09 | — | — | WO | disclosed |
| US-20090042900-A1 | 2,4-DIAMINOQUINAZOLINES FOR SPINAL MUSCULAR ATROPHY | DECODE CHEMISTRY, INC. (US) | 2009-02-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250091983-A1 | CYCLOPENTANE AND CYCLOHEXANE VARIANTS OF 6-PHENYLHEXANAMIDE MITOFUSIN ACTIVATORS AND METHODS FOR USE THEREOF | COQ8A, PDF, HAGH | ALDH1A1 1211/4885MAPT 1541/4885HPGD 256/4885 |
| US-20090042900-A1 | 2,4-DIAMINOQUINAZOLINES FOR SPINAL MUSCULAR ATROPHY | SMN1; SMN2, MUSK, MYT1 | ALDH1A1 1308/4885MAPT 715/4885HPGD 2120/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.